In the USA, the potency of commercially prepared equine tetanus antitoxin is determined by the method outlined in the Code of Federal Regulations, Title 9, Part 113.451. In the current test, commercial equine tetanus antitoxin is tested by a toxin neutralization test in guinea pigs. The in vivo test measures antitoxin content through effectiveness of protection of guinea pigs injected with diluted mixtures of antitoxin and a standard toxin. A competitive enzyme-linked immunosorbent assay, designed as an in vitro alternative to the in vivo test, measures antitoxin content based on a competitive reaction between standard or unknown serum and murine monoclonal antibody specific for tetanus toxin. The monoclonal antibody used in the assay delayed death in mouse passive protection studies and reacted with the C fragment of tetanus toxin. No cross-reaction was observed when the antibody was tested with the toxins of Clostridium chauvoei, C. novyi, C. perfringens, or C. sordellii. The in vitro test will measure the antitoxin content of serum samples containing 100^1500 units of antitoxin. Tetanus antitoxin titers obtained by the competitive enzyme-linked immunosorbent assay compared favorably with the toxin neutralization test conducted in guinea pigs. The in vitro assay serves as a feasible alternative to the in vivo test because it can be completed in less time, is reproducible, and eliminates the use of test animals. ß
Introduction
Tetanus is a highly fatal, infectious disease of all species of domestic animals caused by the toxin of Clostridium tetani. The neurotoxin of C. tetani is exceedingly potent, but there is considerable variation in susceptibility between the animal species, the horse being the most susceptible. Horses suddenly placed at risk of infection from tetanus are commonly injected with approximately 1500 international units (IU) of tetanus antitoxin [1] for short-term passive immunity and an injection of tetanus toxoid for long-term active immunity.
The potency of equine tetanus antitoxin manufactured for veterinary use by licensees in the USA is tested according to the Code of Federal Regulations, Title 9 (9 CFR), Part 113, Section 451 [2] . As outlined in the regulation, a comparative toxin-antitoxin neutralization test is conducted using a standard antitoxin and a standard toxin. The ability of the antitoxin in the test sample to neutralize the standard toxin, as de¢ned by prevention of tetanic para-lysis or death of the guinea pigs injected with the toxin-antitoxin mixture, is compared to that of the standard antitoxin.
An indirect ELISA [3] , developed by the Center for Veterinary Biologics-Laboratory and used to measure the antitoxin titer of serum from guinea pigs vaccinated with tetanus toxoid, was modi¢ed for use in measuring the antitoxin titer of serum from horses hyperimmunized with C. tetani antigen. Although the ELISA accurately measures the antitoxin titers of guinea pig serum, it occasionally overestimates or underestimates the antitoxin titers of horse serum. This study describes the development of a competitive enzyme-linked immunosorbent assay (CELISA) that more accurately measures the antitoxin titer of serum from hyperimmunized horses and compares the CELISA results with those obtained by the toxin neutralization (TN) test in guinea pigs.
Materials and methods

Animals
Guinea pigs weighing 340^380 g were purchased from Central Iowa Cavies, Ames, IA, and Harlan Sprague Dawley, Indianapolis, IN.
BALB/c strain mice were obtained from the National Veterinary Services Laboratories (NVSL), Ames, IA.
Reagents
A crude preparation of tetanus toxin was used as a coating antigen in the CELISA. Brie£y, C. tetani, Harvard strain, was grown in a 14-l fermenter. The culture ¢ltrate was concentrated using an ultra¢lter with nominal molecular mass limits of 10 000 (Millipore Corporation, Bedford, MA). Crude tetanus toxin was inactivated with 0.4% formaldehyde (v/v) and mixed with aluminum potassium sulfate (2.0 mg Al ml 31 ) to prepare the toxoid used for the initial immunization of BALB/c mice for monoclonal antibody production. Tetanus toxin was puri¢ed for subsequent injections in mice by preparative isoelectric focusing (Rotofor, Bio-Rad, Hercules, CA). Samples with isoelectric points between 5.5 and 5.7 were collected. Tetanus monoclonal antibody (mAb) 5C10 was produced by the method of Van Deusen and Whetstone [4] . Brie£y, adult female BALB/c mice were injected subcutaneously with 0.3 ml of tetanus toxoid followed 4 weeks later with a 0.5-ml intravenous injection of puri¢ed toxin. mAb 5C10 (isotype IgG1), which bound to the C fragment of tetanus toxin and provided passive protection to mice when challenged with tetanus toxin, was selected for use in the CELISA.
mAb 5C10 was conjugated with horseradish peroxidase (Sigma, St. Louis, MO) by the method of Ranger and Brown [5] .
Hyperimmune horse serum was obtained from the Colorado Serum Company, Denver, CO, and diluted with normal horse serum (NVSL, Ames, IA) so the mixture contained 500 American antitoxin units (AU) per ml. The antitoxin titer of the mixture was con¢rmed by conducting TN tests in guinea pigs. The standardized serum was used to de¢ne a standard dose^response curve in the CELISA.
CELISA procedure
Flat-bottom 96-well microtitration plates (Nunc F96, Roskilde, Denmark) were coated with C. tetani toxin diluted in 50 mM carbonate-bicarbonate bu¡-er, pH 9.6, and incubated 18^20 h at room temperature in a humidi¢ed chamber on an orbital shaker. The toxin was decanted, and blocking bu¡er (15 mM NaH 2 PO 4 , Na 2 HPO 4 , 345 mM NaCl, with 0.05% normal horse serum, pH 7.9) was added to each well. The plates were incubated 2.5 h at 35³C on an orbital shaker, then they were washed ¢ve times with PBS with 0.05% Tween 20, pH 7.2. Dilutions of the standardized hyperimmune horse serum (500 AU ml 31 ) were made in 100 mM NaH 2 HPO 4 , Na 2 HPO 4 with 50 mM ammonium thiocyanate (NH 4 SCN), pH 6.0. An initial dilution of 1:6000 was made to generate a 500 AU ml 31 standard within the working sensitivity range of the CELISA. From this, incremental dilutions of 4:1, 3:2, 2:3, and 1:4 were made to generate standard samples corresponding to 400, 300, 200, and 100 AU ml 31 . Normal horse serum was diluted 1:6000 to generate a 0 AU ml 31 standard. Each of the standard serum preparations was added to the blocked plate (100 Wl per well, six replicates per dilution). The anti-toxin to be tested was diluted in a similar manner, to generate ¢ve dilutions per serum sample, and was added (100 Wl per well, six replicates per dilution) to the same plate as the standard serum preparation. The plates were incubated 18^20 h with shaking at room temperature in a humidi¢ed chamber, then washed as previously described. mAb 5C10 was diluted 1:14 000 in conjugate diluent (15 mM NaH 2 PO 4 , Na 2 HPO 4 , 345 mM NaCl, pH 7.2) and added (100 Wl per well) to each well and incubated for 90 min at 35³C. After washing ¢ve times, 100 Wl of tetramethylbenzadine substrate was added to each well and incubated at room temperature for 10 min. The colorimetric reaction was stopped with 2.5 M sulfuric acid (100 Wl per well). The absorbance (V450 nm) of each well was measured (Molecular Devices, Sunnyvale, CA), and the replicate measurements were averaged. A best-¢t linear regression line was calculated using the mean absorbance value for the standard serum dilutions. The mean absorbance values of the unknown serum samples were entered into the equation of the standard serum regression line to estimate the antitoxin titers of the unknown samples. Estimates of antitoxin titers derived from individual dilutions of the unknown sample were averaged to derive a mean estimate of antitoxin units per ml.
The following formula was used to determine the slope and correlation coe¤cient (r):
Antitoxin units unknown OD 3y intercept slope Udilution factora6000
Results
The best reproducibility was obtained when the mean absorbance of the 0 AU ml 31 standard was 1.5^1.8 and the mean absorbance of the 500 AU ml 31 standard was 0.5^0.8 (Fig. 1) . The correlation coe¤cient of the standard curve routinely was 0.99. Dilutions of the unknown serum samples with absorbance values of 0.5^1.10 were used to determine the average number of antitoxin units per ml; dilutions with absorbance readings outside this range were less accurate for estimating antitoxin titer. If the absorbance value of all ¢ve dilutions of an unknown sample was below 0.5, the test was considered invalid. The sample was retested at twofold greater dilutions, and estimations of titer from readings falling in the 0.5^1.10 range were then multiplied by 2. If the mean absorbance values of all ¢ve dilutions were above 1.10, the test was also considered invalid. In this case, the dilution factor of serum sample was reduced twofold, and the antitoxin readings calculated from dilutions with absorbance values of 0.51 .10 were divided by 2.
CELISA vs. guinea pig TN test
Nine lots of equine tetanus antitoxin produced by ¢ve manufacturers and the standard C. tetani antitoxin were tested by the guinea pig TN test and Fig. 1 . Typical titration curve calculated for the dilutions of tetanus antitoxin ranging from 0 to 500 AU ml 31 .
CELISA (Table 1 ). The percent variation between the two tests ranged from 31% to +9%. The e¡ect of NH 4 SCN on estimation of antitoxin titer was investigated. Four lots of equine tetanus antitoxin were diluted in bu¡ers that did, or did not, contain NH 4 SCN, and the antitoxin titers were quantitated by CELISA (Table 2 ). Higher antitoxin titers were obtained with three of the four lots when they were diluted in bu¡er without NH 4 SCN.
Discussion
The CELISA quantitates the amount of tetanus antitoxin in horse serum in a simple, humane manner that compares favorably with results obtained by the guinea pig TN test. The CELISA varied 31% to 9% with the results of the TN test. In our laboratory, the guinea pig TN test routinely varies between 5% and 10%; the CELISA values obtained fall within this range.
While developing the CELISA, it was noted that antitoxin readings of given unknown serum samples could be a¡ected by using di¡erent standard sera. Since all of the standard sera used were adjusted to 500 AU ml 31 by the TN test, it was assumed the discrepancy was due to the di¡erence in the a¤nity of the standard sera, which would be more apparent in an in vitro test. Ammonium thiocyanate has been used to measure the relative a¤nity of antibodies in other applications [6] by measuring the ability of antibodies to remain bound to speci¢c antigen when treated with high concentrations of NH 4 SCN. To reduce the variability introduced into the CELI-SA by low a¤nity antibodies in certain horse sera, we incorporated NH 4 SCN into the serum diluent at a level su¤cient to keep antibodies with very low a¤nity from binding to the toxin (Table 2) but not a¡ecting the adsorption of toxin to the microtiter plate.
In conclusion, this study indicates that the CEL-ISA would be a suitable replacement for the in vivo test. It is possible that the CELISA could be modi¢ed slightly to test serum samples containing lower levels of antitoxin. 
